Stockreport

4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF This can be attributed to improved policies following several large drugmakers' drug pricing agreements with the Trump administration. Also, strong merger and acquisitio [Read more]